<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00928980</url>
  </required_header>
  <id_info>
    <org_study_id>MFN-2009-2013</org_study_id>
    <secondary_id>80-82310-98-09018</secondary_id>
    <secondary_id>2008/242</secondary_id>
    <nct_id>NCT00928980</nct_id>
  </id_info>
  <brief_title>Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression</brief_title>
  <official_title>The Clinical and Cost-effectiveness of Mindfulness Based Cognitive Therapy, Maintenance Antidepressant Medication and Its Combination in the Prevention of Relapse in Patients With Recurrent Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the (cost)effectiveness of mindfulness based
      cognitive therapy (MBCT) compared to that of antidepressant medication, and its combination
      with regard to the prevention of relapse or recurrence in patients with recurrent depression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the Netherlands, treatment as usual for patients with (recurrent) Major Depressive
      Disorder consists of maintenance antidepressant medication. Mindfulness-based cognitive
      therapy (MBCT) is a recently developed psychological intervention that appears to be
      promising in terms of preventing relapse or recurrence in patients with recurrent depression.
      It consists of 8 weekly group sessions in which meditation exercises are combined with
      cognitive therapeutic elements such as identifying negative thoughts and monitoring and
      scheduling activities.

      In this study, the (cost)effectiveness of a) MBCT on its own, b) antidepressant medication on
      its own and c) the combination of MBCT and antidepressant medication will be investigated in
      350 patients with recurrent depression who are currently in remission.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relapse/recurrence of Major Depressive Episode</measure>
    <time_frame>3, 6, 9, 12, 15 months</time_frame>
    <description>Relapse or recurrence of depression will be assessed trimonthly using the Structured Clinical Interview for DSM-V (SCID) depression module.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Costs made by consumption of medical care and production loss</measure>
    <time_frame>3, 6, 9, 12, 15 months</time_frame>
    <description>Using prospective calendars and retrospective questionnaires about contacts with health care in the past 3 months (assessed trimonthly) we will estimate the costs of depression health care and the quality of life (selfreport). We will compare the cost-effectiveness ratios between the groups.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">317</enrollment>
  <condition>Depressive Disorder, Major</condition>
  <arm_group>
    <arm_group_label>Mindfulness Based Cognitive Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mindfulness Based Cognitive Therapy and withdrawal of antidepressant medication between the 4th and 5th session, patients being off medication until the end of study period (15 months).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mindfulness Based Cognitive Therapy combined with the use of antidepressant medication during the study (15 months).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimal Medical Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with optimal medical care: therapeutic dose of antidepressant medication during at least 15 months, administered in accordance with current guidelines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness Based Cognitive Therapy</intervention_name>
    <description>Mindfulness Based Cognitive Therapy is an 8-week during group intervention encompassing meditation practice and cognitive therapy techniques.</description>
    <arm_group_label>Mindfulness Based Cognitive Therapy</arm_group_label>
    <arm_group_label>Combination</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Optimal Medical Care</intervention_name>
    <description>Therapeutic dose of antidepressant medication</description>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_label>Optimal Medical Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recurrent Major Depressive Episode (at least 3 previous episodes)

          -  Treatment with therapeutic dose of antidepressant medication during past six months

          -  Currently in full or partial remission

        Exclusion Criteria:

          -  Bipolar disorder (current and previous (hypo)manic episodes)

          -  Psychotic disorder (current and previous)

          -  Neurological or somatic illness affecting depression or outcome measures

          -  Current alcohol or drugs dependency

          -  Use of high dosage benzodiazepines (&gt; 2 mg Lorazepam equivalents daily)

          -  Recent Electro Convulsive Therapy (&lt; 3 months ago)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne EM Speckens, Prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pro Persona</name>
      <address>
        <city>Arnhem</city>
        <state>Gelderland</state>
        <zip>6800</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pro Persona</name>
      <address>
        <city>Ede</city>
        <state>Gelderland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6525 GC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pro Persona</name>
      <address>
        <city>Tiel</city>
        <state>Gelderland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GGZ Noord-Holland-Noord</name>
      <address>
        <city>Alkmaar</city>
        <state>Noord-Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Free University Medical Center and GGZ In Geest</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1000</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AMC Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <state>North Holland</state>
        <zip>1100 DD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GGZ Centraal</name>
      <address>
        <city>Amersfoort</city>
        <state>Utrecht</state>
        <zip>3800</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GGZ Rivierduinen - Leiden</name>
      <address>
        <city>Leiden</city>
        <state>Zuid Holland</state>
        <zip>2300 AT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <state>Zuid Holland</state>
        <zip>2300 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PsyQ</name>
      <address>
        <city>Den Haag</city>
        <state>Zuid-Holland</state>
        <zip>2500</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parnassia ACO Zuid</name>
      <address>
        <city>Den Haag</city>
        <state>Zuid-Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GGZ Duin- en Bollenstreek</name>
      <address>
        <city>Katwijk</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Kuyken W, Byford S, Taylor RS, Watkins E, Holden E, White K, Barrett B, Byng R, Evans A, Mullan E, Teasdale JD. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol. 2008 Dec;76(6):966-78. doi: 10.1037/a0013786.</citation>
    <PMID>19045965</PMID>
  </reference>
  <reference>
    <citation>Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004 Feb;72(1):31-40.</citation>
    <PMID>14756612</PMID>
  </reference>
  <reference>
    <citation>Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000 Aug;68(4):615-23.</citation>
    <PMID>10965637</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2009</study_first_submitted>
  <study_first_submitted_qc>June 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2009</study_first_posted>
  <last_update_submitted>November 7, 2013</last_update_submitted>
  <last_update_submitted_qc>November 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Radboud University</investigator_affiliation>
    <investigator_full_name>Anne Speckens</investigator_full_name>
    <investigator_title>Prof. dr. Anne E.M. Speckens</investigator_title>
  </responsible_party>
  <keyword>Recurrent Major Depressive Disorder</keyword>
  <keyword>Mindfulness Based Cognitive Therapy</keyword>
  <keyword>Cost-effectiveness</keyword>
  <keyword>Antidepressant medication</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

